Table 2 Characteristics of studies
Study | Country | Design | Therapy in the experimental group | Therapy in the control group | Sample size: experiment/control | Stone size: experiment/control, mm | Location of stone | |
|---|---|---|---|---|---|---|---|---|
Proximal ureter | Mid-to-distal ureter | |||||||
Bucci 2018 [11] | Italy | RCT | ESWL within 12 h | dESWL | 36/34 | 9.03/10.68 | 25 | 45 |
Choi 2012 [9] | Korea | R | ESWL within 48 h | dESWL | 153/126 | 7.6 ± 2.5/8.3 ± 3.1 | 183 | 96 |
Cornelius 2020 [12] | Italy | R | ESWL within 48 h | dESWL | 52/52 | 7.1 ± 1.9/7.2 ± 1.9 | 80 | 24 |
Joshi 1999 [13] | UK | R | ESWL within 48 h | dESWL | 16/40 | 8.2/9.3 | 37 | 19 |
Kravchick 2005 [7] | Israel | RCT | ESWL within 48 to 72 h | dESWL | 25/28 | 7.4 ± 2.4/6.9 ± 2.4 | 53 | NA |
Kumar 2010 [14] | India | RCT | ESWL within 48 h | dESWL | 80/80 | 7.3 ± 1.5/7.5 ± 1.7 | 160 | NA |
Seitz 2005 [15] | Austria | R | ESWL within 48 h | dESWL | 44/47 | 8.0 ± 2.4/8.1 ± 2.1 | 91 | NA |
Tombal 2005 [8] | Belgium | RCT | ESWL within 6 h | dESWL | 50/50 | 6.38/4.8 | 46 | 54 |
Uguz 2012 [16] | Turkey | RCT | ESWL within 24 h | dESWL | 32/31 | 8.1 ± 3.2/8.8 ± 2.9 | 41 | 22 |